Related Experiment Video
Updated: Sep 9, 2025
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Early antithrombotic protection of the brain in patients with ischemic stroke]
E A Shirokov1, N V Lomakin1,2, L I Buryachkovskaya3
1Russian Medical Academy of Continuing Professional Education, Moscow, Russia.
Insights
Early antiplatelet therapy offers a safe and effective alternative for acute ischemic stroke patients, especially when reperfusion therapy is not feasible. This approach provides crucial antithrombotic protection shortly after stroke onset.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Thrombosis Research
Background:
- Ischemic stroke, linked to atherosclerosis, is a major cardiovascular complication.
- Current reperfusion therapies (thrombolysis, endovascular) are effective but reach only 10% of patients within the 4.5-hour window.
- Limited treatment options exist for patients outside the narrow therapeutic window.
Purpose of the Study:
- To explore early antiplatelet therapy as an alternative treatment for acute ischemic stroke.
- To evaluate the efficacy and safety of immediate antiplatelet agent use.
- To discuss methods for early antithrombotic brain protection in ischemic stroke patients.
Main Methods:
- Review of recent clinical studies on antiplatelet therapy in acute ischemic stroke.
- Analysis of treatment strategies for patients ineligible for reperfusion.
- Discussion of antithrombotic protection methods based on stroke severity.
Main Results:
- Recent studies show high efficacy and safety of immediate antiplatelet therapy.
- Early antiplatelet use is a viable alternative for patients not receiving thrombolysis or surgery.
- Effective antithrombotic protection can be initiated promptly after stroke onset.
Conclusions:
- Immediate antiplatelet therapy is a promising strategy for acute ischemic stroke.
- This approach expands treatment options beyond the traditional reperfusion window.
- Early intervention improves antithrombotic protection for stroke patients.
Abstract:
Ischemic stroke is the most significant complication of diseases of the cardiovascular system associated with atherosclerosis and atherothrombosis. For the treatment of stroke, pharmacological thrombolysis and endovascular surgical interventions are most effective if medical care is provided within the therapeutic window (4.5 hours). However, not more than 10% of stroke patients receive reperfusion therapy. Early antiplatelet therapy may be an alternative treatment strategy for patients who have not undergone thrombolysis or surgery. Recent clinical studies have demonstrated the high efficacy and safety of immediate (after the first signs of acute cerebrovascular accident) use of antiplatelet agents. The article discusses methods of early antithrombotic protection of the brain in patients with varying severity of ischemic stroke.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
00:49The Blood-brain Barrier
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...